Retraction Note: HIF-1?± and ENPP2 as Biomarkers in Chemotherapy Resistance of Children with Neuroblastoma in south Iraq

Abstract

Editorial Expression of Concern

20 June 2025: Following publication of this paper, the internal audit (consequent to concerns on quality raised by Web of Science) notified Advancements in Life Sciences about suspected plagiarism. By this Editorial Expression of Concern, we alert the scientific community of the errors as we reconcile the records.

Editorial Note

25 June 2025: While rerunning the Turnitin originality analysis, a similarity index of 39% was found for this article. Editorial board of Advancements in Life Sciences has started the process of retracting this article due to the above post-publication findings. The process shall be concluded after registering responses from the authors. Meanwhile, full text of the article shall remain unavailable for citations (this notice has been updated following insights derived from relevant COPE cases and the industry standards). Show of cause notice has also been issued to the concerned editorial team member.

Retraction Note

20 July 2025: The Editor-in-Chief, upon the recommendation of the Inquiry Team, has retracted this article due to plagiarism. An internal audit revealed that several articles, including this one, exhibited a high similarity index without proper disclosure or attribution by the authors. This constitutes a breach of the journal's editorial policy, and the article is therefore being retracted.

The authors have not responded to correspondence regarding this retraction.

The Original Article was published on 20 October 2023.